ClinicalTrials.gg
CompletedNCT04776174Updated Nov 4, 2026Results posted

Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children

An interventional study of Ultrasound using the telerobotic Melody system in Covid19, sponsored by Centre Hospitalier Intercommunal Creteil. Completed at 2 sites in France. Open to participants aged 1 Year to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Centre Hospitalier Intercommunal Creteil · Not applicable, Interventional, and Diagnostic

How we know

Updated Nov 4, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
1 Year to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in COVID-19 by Centre Hospitalier Intercommunal Creteil — none open to participants now, 1 under way, none of them phase 3. COVID-19 · Centre Hospitalier Intercommunal Creteil.

Started
2021
with 3 others
No phase
4 of 14
none open now
Registered
11th of 14
by date

Among the 14 studies in COVID-19 by Centre Hospitalier Intercommunal Creteil, this one is one of 4 that started in 2021, is one of 4 with no phase, and was the 11th registered.

COVID-19

7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.

Browse COVID-19 studies →

Open to participants now

None of the 14 studies in COVID-19 by Centre Hospitalier Intercommunal Creteil is open now. The open studies under COVID-19, anywhere →

Where they have run

Who these studies take

Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.

This study: 1 Year to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 14 studies in COVID-19 by Centre Hospitalier Intercommunal Creteil as a file.
02

Study summary

In children with Covid-19, the diagnosis of Kawasaki Disease (KD) and pneumonia should be made very quickly. However, the regional hospitals surrounding Paris don't have the required expertise. The use of MELODY allows the paediatric team to quickly carry out the necessary examinations while avoiding the movement of patients and the risk of contamination.

The MELODY remote system developed by the company AdEchoTech is a CE marking telemedicine technique, allowing an expert to perform an ultrasound scan on a distant patient (several hundred/thousands of kms). The Melody system makes it possible to optimize ultrasound expertise resources wherever they are located (all specialties combined) The feasibility of the clinical use of telerobotic sonography has been demonstrated in adults for abdominal, cardiac and prenatal exam. Thus, the aim of this study is to assess the feasibility of this system in children.

03

Conditions studied

  • Covid19

Browse trials for

04

Who can participate

Ages eligible
1 Year to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient from 1 year to 10 years
  • Patient requiring an ultrasound exam (thoracic, abdominal or cardiac)
  • French social security affiliation

Exclusion criteria

Exclusion Criteria:

  • Obesity defined by a greater than 30
  • Open wound making it impossible to carry out an ultrasound scan
  • Algetic patient
  • Instability of vital functions
  • Impossible to remain in a seated position
  • Refusal to participate in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    standard and telerobotic ultrasound

    Included patients will have both ultrasound examination: standard ultraosound (abdominal, cardiac or pulmonary depending on the prescription and telerobotic ultrasound

    Device: Ultrasound using the telerobotic Melody system

Interventions

  • DeviceUltrasound using the telerobotic Melody system

    The children will first have a telerobotic ultrasound abdominal, pulmonary or cardiac followed by a classical ultrasound.

06

What researchers measure

Primary outcomes

  1. Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa Coefficient

    Agreement between telerobotic and conventional ultrasound examinations was assessed using the Cohen kappa coefficient based on the overall examination conclusions (normal or abnormal) obtained by the two methods. Kappa values range from 0 to 1, where 0 indicates no agreement beyond chance and 1 indicates perfect agreement; higher values indicate better agreement between the two examination methods.

    Time frame: 1 day

Secondary outcomes

  1. Parent Acceptance of Telerobotic Ultrasound

    Parents completed a 5-point Likert questionnaire immediately after the telerobotic ultrasound examination. Responses were reported as the number of participants selecting each response category. Higher levels of agreement indicate greater acceptance.

    Time frame: Up to 4 hours

  2. Patient Site Assistant Satisfaction

    Medical assistant satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

    Time frame: Up to 4 hours

  3. Sonographer Satisfaction

    Sonographer satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

    Time frame: Up to 4 hours

  4. Duration of Ultrasound Examination

    Duration of the ultrasound examination performed using the telerobotic and conventional ultrasound systems.

    Time frame: Within 1 day (during the paired standard and telerobotic ultrasound examinations)

07

Results

Posted Nov 4, 2026

Participant flow

Participant flow — Overall Study
MilestoneStandard and Telerobotic Ultrasound
Started40
Completed38
Not completed2

Outcome measures

PrimaryAgreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa Coefficient

Agreement between telerobotic and conventional ultrasound examinations was assessed using the Cohen kappa coefficient based on the overall examination conclusions (normal or abnormal) obtained by the two methods. Kappa values range from 0 to 1, where 0 indicates no agreement beyond chance and 1 indicates perfect agreement; higher values indicate better agreement between the two examination methods.

Time frame:
1 day
Reported as:
Number · Kappa coefficient
Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa Coefficient
Kappa coefficientStandard and Telerobotic Ultrasound
Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa Coefficient0.74 (0.53 to 0.94)
SecondaryParent Acceptance of Telerobotic Ultrasound

Parents completed a 5-point Likert questionnaire immediately after the telerobotic ultrasound examination. Responses were reported as the number of participants selecting each response category. Higher levels of agreement indicate greater acceptance.

Time frame:
Up to 4 hours
Reported as:
Count of participants · Participants
Parent Acceptance of Telerobotic Ultrasound
ParticipantsStandard and Telerobotic Ultrasound
Strongly agree23
Agree10
Neither agree nor disagree3
Disagree1
Strongly disagree0
SecondaryPatient Site Assistant Satisfaction

Medical assistant satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

Time frame:
Up to 4 hours
Reported as:
Count of participants · Participants
Patient Site Assistant Satisfaction
ParticipantsStandard and Telerobotic Ultrasound
Strongly agree37
Agree0
Neither agree nor disagree0
Disagree0
Strongly disagree0
SecondarySonographer Satisfaction

Sonographer satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

Time frame:
Up to 4 hours
Reported as:
Count of participants · Participants
Sonographer Satisfaction
ParticipantsStandard and Telerobotic Ultrasound
Strongly agree31
Agree3
Neither agree nor disagree2
Disagree2
Strongly disagree0
SecondaryDuration of Ultrasound Examination

Duration of the ultrasound examination performed using the telerobotic and conventional ultrasound systems.

Time frame:
Within 1 day (during the paired standard and telerobotic ultrasound examinations)
Reported as:
Mean · minutes
Duration of Ultrasound Examination
minutesStandard UltrasoundTelerobotic Ultrasound
Duration of Ultrasound Examination13.9 ± 11.226 ± 12.5

Adverse events

Collected over During and immediately after the ultrasound examinations (within 3 hours).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard and Telerobotic Ultrasound0/38 (0%)0/38 (0%)2/38 (5.3%)
Most frequent other events
Most frequent other events
EventStandard and Telerobotic Ultrasound
Pain during telerobotic examinationGastrointestinal disorders2/38

Baseline characteristics

Age, Continuous
Age, Continuous(years)Standard and Telerobotic Ultrasound
Mean5.7 ± 2.7
Sex: Female, Male
Sex: Female, Male(Participants)Standard and Telerobotic Ultrasound
Female19
Male19
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Standard and Telerobotic Ultrasound
Region of Enrollment
Region of Enrollment(participants)Standard and Telerobotic Ultrasound
France38
08

Study locations

2 sites
  • CHI Créteil
    Créteil, 94000, France
  • CHI Villeneuve-Saint-Georges
    Villeneuve-Saint-Georges, France
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Nov 2021, 8 months.

Results were first posted in Nov 2026, 5 years after primary completion.

Of 1,337 non-industry interventional studies with no phase under COVID-19, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 20. This study's 8 months is below that.

Counting every sponsor, half of 1,475 studies reached it within 9 months; a quarter within 3 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2021
First posted
Mar 1, 2021
StartActual
Mar 1, 2021
Primary completionActual
Nov 3, 2021
CompletionActual
Nov 3, 2021
Results first posted
Nov 4, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 4, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Number of normal and abnormal standard and telerobotic ultrasound examinationsNow Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa CoefficientTime frame: 1 day
Nov 4, 2026
Secondary outcomes
2 edited, 2 added, 3 removed
What changed in the outcomes
  • EditedParent satisfactionSonographer SatisfactionTime frame: Up to 4 hours
  • EditedMedical assistant satisfactionPatient Site Assistant SatisfactionTime frame: Up to 4 hours
  • AddedParent Acceptance of Telerobotic UltrasoundTime frame: Up to 4 hours
  • AddedDuration of Ultrasound ExaminationTime frame: Within 1 day (during the paired standard and telerobotic ultrasound examinations)
  • RemovedAge of participantsTime frame: At baseline
  • RemovedNumber of anomalies foundTime frame: Up to 4 hours
  • RemovedSonographer satisfactionTime frame: Up to 4 hours
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Number of normal and abnormal standard and telerobotic ultrasound examinationsNow Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa CoefficientTime frame: 1 day
    Secondary outcomes 2 edited, 2 added, 3 removed
    What changed in the outcomes
    • EditedParent satisfactionSonographer SatisfactionTime frame: Up to 4 hours
    • EditedMedical assistant satisfactionPatient Site Assistant SatisfactionTime frame: Up to 4 hours
    • AddedParent Acceptance of Telerobotic UltrasoundTime frame: Up to 4 hours
    • AddedDuration of Ultrasound ExaminationTime frame: Within 1 day (during the paired standard and telerobotic ultrasound examinations)
    • RemovedAge of participantsTime frame: At baseline
    • RemovedNumber of anomalies foundTime frame: Up to 4 hours
    • RemovedSonographer satisfactionTime frame: Up to 4 hours
    + 3 other changes: verification date, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04776174
Collaborators
ADECHOTECH
Responsible party
Sponsor
First posted
Mar 1, 2021
Start date
Mar 1, 2021
Primary completion
Nov 3, 2021
Completion
Nov 3, 2021
Results posted
Nov 4, 2026
Last update
Nov 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion